JA PCM
@japcm.bsky.social
Strengthens the personalised cancer medicine network across Europe
Across Europe, cancer care is evolving - and JA PCM will help lead the way!
🌍 With 𝟭𝟰𝟱 𝐩𝐚𝐫𝐭𝐧𝐞𝐫𝐬 𝐮𝐧𝐢𝐭𝐞𝐝 𝐢𝐧 𝐨𝐧𝐞 𝐄𝐮𝐫𝐨𝐩𝐞𝐚𝐧 𝐉𝐨𝐢𝐧𝐭 𝐀𝐜𝐭𝐢𝐨𝐧, JA PCM is strengthening the PCM network across Europe.
🔎 Curious to learn more about our ambitious European Joint Action? Take a look: zenodo.org/records/1842...
🌍 With 𝟭𝟰𝟱 𝐩𝐚𝐫𝐭𝐧𝐞𝐫𝐬 𝐮𝐧𝐢𝐭𝐞𝐝 𝐢𝐧 𝐨𝐧𝐞 𝐄𝐮𝐫𝐨𝐩𝐞𝐚𝐧 𝐉𝐨𝐢𝐧𝐭 𝐀𝐜𝐭𝐢𝐨𝐧, JA PCM is strengthening the PCM network across Europe.
🔎 Curious to learn more about our ambitious European Joint Action? Take a look: zenodo.org/records/1842...
JA PCM Project Leaflet (MS10)
𝐌𝐞𝐞𝐭 𝐭𝐡𝐞 𝐄𝐔 𝐉𝐨𝐢𝐧𝐭 𝐀𝐜𝐭𝐢𝐨𝐧 𝐨𝐧 𝐏𝐞𝐫𝐬𝐨𝐧𝐚𝐥𝐢𝐬𝐞𝐝 𝐂𝐚𝐧𝐜𝐞𝐫 𝐌𝐞𝐝𝐢𝐜𝐢𝐧𝐞 (𝐏𝐂𝐌)Across Europe, cancer care is evolving - and JA PCM will help lead the way! 🌍 With 𝟭𝟰𝟱 𝐩𝐚𝐫𝐭𝐧𝐞𝐫𝐬 𝐮𝐧𝐢𝐭𝐞𝐝 𝐢𝐧 𝐨𝐧𝐞 𝐄𝐮𝐫𝐨𝐩𝐞𝐚𝐧 𝐉𝐨𝐢𝐧𝐭 𝐀𝐜𝐭𝐢𝐨𝐧, JA PC...
zenodo.org
January 30, 2026 at 9:32 AM
Across Europe, cancer care is evolving - and JA PCM will help lead the way!
🌍 With 𝟭𝟰𝟱 𝐩𝐚𝐫𝐭𝐧𝐞𝐫𝐬 𝐮𝐧𝐢𝐭𝐞𝐝 𝐢𝐧 𝐨𝐧𝐞 𝐄𝐮𝐫𝐨𝐩𝐞𝐚𝐧 𝐉𝐨𝐢𝐧𝐭 𝐀𝐜𝐭𝐢𝐨𝐧, JA PCM is strengthening the PCM network across Europe.
🔎 Curious to learn more about our ambitious European Joint Action? Take a look: zenodo.org/records/1842...
🌍 With 𝟭𝟰𝟱 𝐩𝐚𝐫𝐭𝐧𝐞𝐫𝐬 𝐮𝐧𝐢𝐭𝐞𝐝 𝐢𝐧 𝐨𝐧𝐞 𝐄𝐮𝐫𝐨𝐩𝐞𝐚𝐧 𝐉𝐨𝐢𝐧𝐭 𝐀𝐜𝐭𝐢𝐨𝐧, JA PCM is strengthening the PCM network across Europe.
🔎 Curious to learn more about our ambitious European Joint Action? Take a look: zenodo.org/records/1842...
Reposted by JA PCM
🚀 We took part in the kick-off meeting of the @japcm.bsky.social: a new EU initiative to expand access to personalised cancer care across Europe.
🔬 As partners, VHIO lead a pilot to create a supranational Molecular Tumor Board for rare and complex cases and work on harmonising data collection.
🔬 As partners, VHIO lead a pilot to create a supranational Molecular Tumor Board for rare and complex cases and work on harmonising data collection.
January 21, 2026 at 6:02 PM
🚀 We took part in the kick-off meeting of the @japcm.bsky.social: a new EU initiative to expand access to personalised cancer care across Europe.
🔬 As partners, VHIO lead a pilot to create a supranational Molecular Tumor Board for rare and complex cases and work on harmonising data collection.
🔬 As partners, VHIO lead a pilot to create a supranational Molecular Tumor Board for rare and complex cases and work on harmonising data collection.
We’re excited to kick off the Joint Action on Personalised Cancer Medicine (JA PCM) today in Brussels 🎉
Funded by #EU4Health, 146 organisations from 29 European countries are joining forces to advance personalised cancer care across the full patient pathway, from prevention to follow-up.
Funded by #EU4Health, 146 organisations from 29 European countries are joining forces to advance personalised cancer care across the full patient pathway, from prevention to follow-up.
January 14, 2026 at 9:44 AM
We’re excited to kick off the Joint Action on Personalised Cancer Medicine (JA PCM) today in Brussels 🎉
Funded by #EU4Health, 146 organisations from 29 European countries are joining forces to advance personalised cancer care across the full patient pathway, from prevention to follow-up.
Funded by #EU4Health, 146 organisations from 29 European countries are joining forces to advance personalised cancer care across the full patient pathway, from prevention to follow-up.